KRAS and non-small cell lung carcinoma: In Latin America, the frequency of NSCLC (in particular lung AC) with KRAS mutations corresponds to 14% [48], with little differences, ranging from 12.9% in Colombia to 15.9% in Mexico and 16.8% in Peru [48].